Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial-Reference-Cited by-同舟云学术

Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial

Published:2018-04-27 Issue:8 Volume:33 Page:1287-1297
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Lipsmeier Florian¹,Taylor Kirsten I.¹,Kilchenmann Timothy¹,Wolf Detlef¹,Scotland Alf¹,Schjodt-Eriksen Jens¹,Cheng Wei-Yi¹,Fernandez-Garcia Ignacio¹,Siebourg-Polster Juliane¹,Jin Liping¹,Soto Jay²,Verselis Lynne¹,Boess Frank¹,Koller Martin²,Grundman Michael²³,Monsch Andreas U.⁴,Postuma Ronald B.⁵,Ghosh Anirvan¹,Kremer Thomas¹,Czech Christian¹,Gossens Christian¹^ORCID,Lindemann Michael¹

Affiliation:

1. Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience, Ophthalmology, and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.; Basel Switzerland

2. Prothena Biosciences Inc.; South San Francisco California USA

3. Global R&D Partners, LLC; San Diego California USA

4. Felix Platter Hospital, University Center for Medicine of Aging, Memory Clinic, Basel, Switzerland; University of Basel, Faculty of Psychology; Basel Switzerland

5. Department of Neurology; McGill University, Montreal General Hospital; Montreal Quebec Canada

Funder

F. Hoffmann-La Roche

Prothena Biosciences Inc.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27376/fullpdf

Reference75 articles.

1. New methods for the assessment of Parkinson's disease (2005 to 2015): a systematic review;Sanchez-Ferro;Mov Disord,2016